Cardioprotective interventions for cancer patients receiving anthracyclines (Cochrane Review) (2011)

Peer-Reviewed Study · van Dalen EC, Caron HN, Dickinson HO, Kremer LC · June 15, 2011

van Dalen EC et al., 2011-06-15: Cochrane review of randomised trials of cardioprotective agents in cancer patients receiving anthracyclines. CoQ10 was one of eight agents with eligible trials, and the review found that no individual study showed a cardioprotective effect.

All studies had methodological limitations and for the first seven agents there were too few studies to allow pooling of results. None of the individual studies showed a cardioprotective effect.

Abstract, Main results

van Dalen EC et al., 2011-06-15: Cochrane review of randomised trials of cardioprotective agents in cancer patients receiving anthracyclines. CoQ10 was one of eight agents with eligible trials, and the review found that no individual study showed a cardioprotective effect. Study type: review.